| BAP1 loss defines a new class of renal cell carcinoma S Peña-Llopis, S Vega-Rubín-de-Celis, A Liao, N Leng, A Pavía-Jiménez, ... Nature genetics 44 (7), 751-759, 2012 | 977 | 2012 |
| Targeting renal cell carcinoma with a HIF-2 antagonist W Chen, H Hill, A Christie, MS Kim, E Holloman, A Pavia-Jimenez, ... Nature 539 (7627), 112-117, 2016 | 653 | 2016 |
| Synthetic lethal screen identification of chemosensitizer loci in cancer cells AW Whitehurst, BO Bodemann, J Cardenas, D Ferguson, L Girard, ... Nature 446 (7137), 815-819, 2007 | 583 | 2007 |
| Regulation of TFEB and V‐ATPases by mTORC1 S Peña‐Llopis, S Vega‐Rubin‐de‐Celis, JC Schwartz, NC Wolff, ... The EMBO journal 30 (16), 3242-3258, 2011 | 483 | 2011 |
| Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation P Kapur, S Peña-Llopis, A Christie, L Zhrebker, A Pavía-Jiménez, ... The lancet oncology 14 (2), 159-167, 2013 | 478 | 2013 |
| RETRACTED ARTICLE: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 JY Krzeszinski, W Wei, HD Huynh, Z Jin, X Wang, TC Chang, XJ Xie, L He, ... Nature 512 (7515), 431-435, 2014 | 367 | 2014 |
| Inadequate nutrient intakes are common and are associated with low diet variety in rural, community-dwelling elderly TA Marshall, PJ Stumbo, JJ Warren, XJ Xie The Journal of nutrition 131 (8), 2192-2196, 2001 | 320 | 2001 |
| Phase I dose-escalation study of stereotactic body radiation therapy for low-and intermediate-risk prostate cancer TP Boike, Y Lotan, LC Cho, J Brindle, P DeRose, XJ Xie, J Yan, R Foster, ... Journal of clinical oncology 29 (15), 2020, 2011 | 270 | 2011 |
| Oral health, nutrient intake and dietary quality in the very old TA Marshall, JJ Warren, JS Hand, XJ Xie, PJ Stumbo The Journal of the American Dental Association 133 (10), 1369-1379, 2002 | 248 | 2002 |
| A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer AN Elayadi, KN Samli, L Prudkin, YH Liu, A Bian, XJ Xie, II Wistuba, ... Cancer research 67 (12), 5889-5895, 2007 | 216 | 2007 |
| Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer DWN Kim, LC Cho, C Straka, A Christie, Y Lotan, D Pistenmaa, ... International Journal of Radiation Oncology* Biology* Physics 89 (3), 509-517, 2014 | 207 | 2014 |
| A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma S Sivanand, S Peña-Llopis, H Zhao, B Kucejova, P Spence, ... Science translational medicine 4 (137), 137ra75-137ra75, 2012 | 199 | 2012 |
| A transistor-like pH nanoprobe for tumour detection and image-guided surgery T Zhao, G Huang, Y Li, S Yang, S Ramezani, Z Lin, Y Wang, X Ma, Z Zeng, ... Nature biomedical engineering 1 (1), 0006, 2016 | 180 | 2016 |
| A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma MN Farley, LS Schmidt, JL Mester, S Pena-Llopis, A Pavia-Jimenez, ... Molecular cancer research 11 (9), 1061-1071, 2013 | 180 | 2013 |
| Evidence-based assessment of acute pain in older adults: current nursing practices and perceived barriers K Herr, MG Titler, ML Schilling, JL Marsh, X Xie, G Ardery, WR Clarke, ... The Clinical journal of pain 20 (5), 331-340, 2004 | 174 | 2004 |
| Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma CR Gil del Alcazar, MC Hardebeck, B Mukherjee, N Tomimatsu, X Gao, ... Clinical cancer research 20 (5), 1235-1248, 2014 | 172 | 2014 |
| Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis SS Wang, YF Gu, N Wolff, K Stefanius, A Christie, A Dey, RE Hammer, ... Proceedings of the National Academy of Sciences 111 (46), 16538-16543, 2014 | 161 | 2014 |
| TGF-β1–induced expression of human Mdm2 correlates with late-stage metastatic breast cancer S Araki, JA Eitel, CN Batuello, K Bijangi-Vishehsaraei, XJ Xie, ... The Journal of clinical investigation 120 (1), 290-302, 2010 | 159 | 2010 |
| Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial R Hannan, V Tumati, XJ Xie, LC Cho, BD Kavanagh, J Brindle, D Raben, ... European Journal of Cancer 59, 142-151, 2016 | 150 | 2016 |
| Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade YF Gu, S Cohn, A Christie, T McKenzie, N Wolff, QN Do, ... Cancer discovery 7 (8), 900-917, 2017 | 148 | 2017 |
